But its their weight loss effects that have caused a surge in interest
As GLP-1s gain approvals for additional disease areas - Novo is studying semaglutide in addiction, osteoarthritis, and MASHthe companies continue extending patent protection through method-of-use claims that could sustain market exclusivity well beyond initial compound patents [40]
It would be at aforementioned 0.6-milligram dose, as opposed to Novos version of 2.4 milligrams
The most obvious phenotype of the mutant animals was a lack of motor coordination
MNT had the opportunity to speak with Laurie Glasser, MD, a physical medicine and rehabilitation physician at Hackensack Meridian Healths Jersey Shore University Medical Center in New Jersey, as to why GLP-1 use might be linked to a higher risk for osteoporosis, gout, and osteomalacia in people with type 2 diabetes and obesity
Smooth blending and well-formulated powders create a clean, easy mouthfeel